EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSPCTG00005004764
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Trifunctional Purine Biosynthetic Protein Adenosine-3

Ensembl ID : ENSPCTG00005013757
Gene Symbol: LOC102994250
3 Cross references
210 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSPCTG00005008408
Gene Symbol: TUBA1B
2 Cross references
189 Possible Orthologues:

Tubulin Alpha 3c

Ensembl ID : ENSPCTG00005012020
Gene Symbol: TUBA3C
1 Cross references
124 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPCTG00005020138
Gene Symbol: TUBA4A
1 Cross references
224 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSPCTG00005020863
Gene Symbol: LOC102980636
3 Cross references
113 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSPCTG00005015276
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPCTG00005011227
Gene Symbol: TUBB3
1 Cross references
146 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSPCTG00005007195
Gene Symbol: TUBB4B
3 Cross references
316 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPCTG00005014301
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPCTG00005006804
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPCTG00005008078
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).